Pharmaceutical Excipients Market Size, Share, Industry Trends and Forecast to 2033
This report provides a comprehensive analysis of the pharmaceutical excipients market, including insights on market size, growth trends, regional performance, segmentation by product type, and key players through the forecast period of 2023 to 2033.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $6.50 Billion |
| CAGR (2023-2033) | 6.2% |
| 2033 Market Size | $12.04 Billion |
| Top Companies | BASF SE, Evonik Industries AG, FMC Corporation, Ashland Global Holdings Inc. |
| Last Modified Date | 15 Nov 2024 |
Pharmaceutical Excipients Market Report (2023 - 2033)
Pharmaceutical Excipients Market Overview
What is the Market Size & CAGR of Pharmaceutical Excipients market in 2023 and 2033?
Pharmaceutical Excipients Industry Analysis
Pharmaceutical Excipients Market Segmentation and Scope
Request a custom research report for industry.
Pharmaceutical Excipients Market Analysis Report by Region
Europe Pharmaceutical Excipients Market Report:
The European pharmaceutical excipients market is predicted to grow from $1.70 billion in 2023 to $3.15 billion by 2033. This growth is fueled by stringent pharmaceutical regulations, a strong emphasis on innovation, and the presence of major pharmaceutical companies that promote extensive R&D efforts.Asia Pacific Pharmaceutical Excipients Market Report:
In the Asia Pacific region, the pharmaceutical excipients market is anticipated to grow from $1.33 billion in 2023 to $2.47 billion by 2033. This growth is driven by the expanding pharmaceutical industry, increasing healthcare expenditure, and rising demand for generic medicines, particularly in countries like China and India.North America Pharmaceutical Excipients Market Report:
North America is expected to maintain a significant market presence, with an increase from $2.17 billion in 2023 to $4.02 billion by 2033. The market growth is driven by the high demand for advanced drug formulations and robust research and development activities in pharmaceutical companies across the United States and Canada.South America Pharmaceutical Excipients Market Report:
The South American market for pharmaceutical excipients is projected to expand from $0.58 billion in 2023 to $1.07 billion by 2033. Factors influencing this growth include improvements in healthcare infrastructure, increased focus on pharmaceutical manufacturing, and the rising prevalence of diseases requiring advanced treatments.Middle East & Africa Pharmaceutical Excipients Market Report:
In the Middle East and Africa, the pharmaceutical excipients market is likely to rise from $0.72 billion in 2023 to $1.33 billion by 2033. The growth is supported by emerging pharmaceutical markets in countries like South Africa and the UAE, along with government initiatives to enhance healthcare systems.Request a custom research report for industry.
Pharmaceutical Excipients Market Analysis By Type
Global Pharmaceutical Excipients Market, By Type Market Analysis (2023 - 2033)
Binders dominate the pharmaceutical excipients market with a size of $3.64 billion in 2023, projected to reach $6.74 billion by 2033. They hold a market share of 55.94%. Fillers, with a current market size of $1.54 billion and a projected size of $2.85 billion, represent 23.65% of the market share. Other significant segments include disintegrants and coatings, contributing to the overall industry dynamics.
Pharmaceutical Excipients Market Analysis By Functionality
Global Pharmaceutical Excipients Market, By Functionality Market Analysis (2023 - 2033)
Functionality is critical in the excipients market, where stabilizers account for a substantial portion, with $4.16 billion in 2023 and projected growth to $7.71 billion by 2033, holding a market share of 64.01%. Coating agents and preservatives also play important roles, indicating the necessity for advanced and effective excipients in drug formulations.
Pharmaceutical Excipients Market Analysis By Application
Global Pharmaceutical Excipients Market, By Application Market Analysis (2023 - 2033)
The application-driven analysis shows that oral drugs account for a considerable portion with a market size of $4.16 billion and are forecasted to grow to $7.71 billion by 2033. Injectable drugs also highlight significant growth, reflecting the shift towards more biologic and innovative therapies in terms of excipient-demanding formulations.
Pharmaceutical Excipients Market Analysis By Manufacturing Technique
Global Pharmaceutical Excipients Market, By Manufacturing Technique Market Analysis (2023 - 2033)
Various manufacturing techniques play a role in excipient production, with dry granulation showing a strong market presence. With a current market size of $4.16 billion and growth expected, techniques like wet granulation and direct compression also contribute significantly, reflecting advances in manufacturing capabilities.
Pharmaceutical Excipients Market Analysis By End User
Global Pharmaceutical Excipients Market, By End-User Market Analysis (2023 - 2033)
Pharmaceutical manufacturers dominate this segment with a market size of $4.16 billion in 2023. Biotechnology companies also hold a critical position with a market size of $1.87 billion, indicative of the increasing production of biologics and the need for specialized excipients.
Pharmaceutical Excipients Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Pharmaceutical Excipients Industry
BASF SE:
A global leader in chemical production that also specializes in pharmaceutical excipients, offering a wide range of high-quality solutions to enhance drug formulation.Evonik Industries AG:
Known for its diverse product portfolio, Evonik focuses on excipients for biopharmaceuticals and advanced drug delivery systems.FMC Corporation:
FMC provides innovative excipients and has a strong commitment to sustainability and improving patient outcomes through effective drug formulation.Ashland Global Holdings Inc.:
With a focus on specialty chemicals, Ashland develops excipients for key pharmaceutical applications, supporting global pharmaceutical manufacturers.We're grateful to work with incredible clients.
